(Q45864537)

English

Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

0 references

author name string

Kim JM

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Jeong JG

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Ho SH

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Hahn W

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Park EJ

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Kim S

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Yu SS

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Lee YW

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Kim S

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

18

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

1543-1550

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302042

0 references

Experimental animal models resembling rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Nonviral vectors in the new millennium: delivery barriers in gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Collagen autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Type II collagen autoimmunity in animals and provocations leading to arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

21 January 2018

Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1–stimulated cartilage erosion and chondrocyte responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302042

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/12907945

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45864537&oldid=2087618582"